This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

10 Best-Performing Mutual Funds of 2011

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

The $34 million Kinetics Medical No Load Fund (MEDRX) has climbed 13.8% this year, including a particularly strong three-month gain of 12.8%.

Its largest holding, Biogen Idec (BIIB), at 8.9% of the fund, is up 48% this year. The company is a drug developer with a wide range of products.

Novartis (NVS), at 6.2% of the fund, is up 5.9% this year. Its business includes branded and generic pharmaceuticals, vaccines and consumer products.

Life Technologies (LIFE), at 6.1% of the portfolio, is down 4.9% this year. It develops biotechnology tools.

Alpine Realty Income & Growth (AIGYX) is up 13.2% this year, including a 6.3% gain over the past three months. It invests primarily in real estate investment trusts (REITs).

Its largest holding, Simon Property Group (SPG), at 6.5% of the fund, has jumped 16.4% this year. The company is the largest retail REIT in the U.S., and its portfolio includes shopping malls, premium outlet centers and international properties. Its holdings recently included 393 properties, about half of which were wholly owned.

Boston Properties (BXP), which makes up 5.6% of the fund, has risen 24.6% this year. It owns over 100 office buildings in major cities as well as at least 20 office and technical properties, a hotel, as well as residential and retail properties.

Vornado Realty Trust (VNO), at 5% of the fund, is up 13.6% this year. It owns mostly office properties in New York and Washington D.C., and shopping malls and retail properties nationwide.

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player
3 of 6

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $93.21 -0.44%
FB $117.80 -0.22%
GOOG $701.26 0.80%
TSLA $211.53 -4.96%
YHOO $36.94 2.61%


Chart of I:DJI
DOW 17,660.71 +9.45 0.05%
S&P 500 2,050.63 -0.49 -0.02%
NASDAQ 4,717.0940 -8.5450 -0.18%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs